Evidence map›Paper›PMID 41949792›Full record

ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2026

Effect of Three Types of Specially-Designed Myopia Control Spectacle Lenses on Astigmatism: A Two-Year Result.

Ke Wen, Bi Yang, Longqian Liu, Pauline Cho

Abstract read
In one paragraph

Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ke WenDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.ORCID http://orcid.org/0009-0001-1782-3412
Bi YangDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China. yangbi19830418@126.com.ORCID http://orcid.org/0000-0001-6079-789X
Longqian LiuDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.ORCID http://orcid.org/0000-0002-2265-4625
Pauline ChoDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.ORCID http://orcid.org/0000-0002-7866-7513

Funding

1·3·5 project for disciplines of excellence - Clinical Research Fund, West China Hospital, Sichuan University 2024HXFH043
6 · The paper itself

Abstract

purposeThis study sought to determine whether specially-designed myopia control spectacle lenses had any effect on astigmatism in clinical practice.

methodsMedical records of 74 patients (age: 6 to 12 years old) involving the use of MyoVision (n = 23), DIMS (n = 22) and Stellest lenses (n = 29) were collected from the West China Hospital. Data collection included baseline age, sex and spectacle lens prescription at baseline and at the 2-year follow-up. Astigmatism, determined by cycloplegic objective and subjective refraction, was divided into its power vector components, J

resultsAfter 2 years of lens wear, for the MyoVision, DIMS and Stellest groups, the total astigmatism increased by -0.41 ± 0.29 D, -0.42 ± 0.34 D and -0.41 ± 0.31 D, respectively (all p < 0.001). The J

conclusionThe use of specially-designed myopia control spectacle lenses over 2 years resulted in a slight, but clinically insignificant (<0.50 D) increase in refractive astigmatism. The increase was not associated with lens type, but rather with the increase in myopia.

Indexed as

AstigmatismEyeglassesMyopiaRefraction, OcularChildEquipment DesignFemaleFollow-Up StudiesHumansMaleRetrospective StudiesVisual AcuityAstigmatismChildrenMyopiaMyopia control spectacle lenses

Identifiers

PMID41949792
PMCPMC13368835

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.